Filtered By:
Vaccination: Varicella-Zoster Virus Vaccine
This page shows you your search results in order of relevance. This is page number 20.
Order by Relevance | Date
Total 2327 results found since Jan 2013.
Safety and efficacy in the nursing care of people with rheumatic diseases on janus kinase inhibitor therapy
Rheumatol Int. 2022 Aug 18. doi: 10.1007/s00296-022-05185-2. Online ahead of print.ABSTRACTNurses's support of patients needs an evidence base as much as that of specialists management. However, some more practical aspects need specific questions that are not addressed in medical societies' recommendations. Our objective was to investigate the effect of Janus kinase inhibitors (jakinibs) on efficacy, safety, infections, cardiovascular risk, vaccination, pregnancy and lactation, interactions, surgery, and switch in adult patients with rheumatic diseases. We used the methodology for rapid reviews. Medline was searched for sy...
Source: Herpes - August 18, 2022 Category: Infectious Diseases Authors: Laura Lorena Castiblanco Mar ía Jesús García de Yébenes Jose Mar ía Martín Martín Loreto Carmona Source Type: research
Factors associated with pneumococcal vaccine uptake among vulnerable older adults in the United States primary care setting
This study assessed factors associated with having gotten a pneumococcal vaccine among vulnerable adults aged 50 and older. This study used the 2018 Medical Expenditure Panel Survey nationally representative dataset. Eligible individuals were aged 50-64 with an 'at risk' health condition or ≥65 years and had a primary care provider as their usual source of care (N = 3,760). Binary logistic regression was used to test factors (identified from literature) for a significant association with getting the pneumococcal vaccine. Factors with significant associations were entered into an adjusted multivariable logistic regression...
Source: Vaccine - October 13, 2022 Category: Allergy & Immunology Authors: Megan Whaley David R Axon Source Type: research
Safety Surveillance of Varicella Vaccines in the Vaccine Adverse Event Reporting System, United States, 2006-2020
CONCLUSIONS: No new or unexpected safety findings were detected for VAR and MMRV given as recommended, reinforcing the favorable safety profiles of these vaccines. Providers should obtain specimens for viral testing and strain-typing for serious AEs if they consider vVZV as the possible causative agent.PMID:36265846 | DOI:10.1093/infdis/jiac306
Source: Herpes - October 20, 2022 Category: Infectious Diseases Authors: Pedro L Moro Jessica Leung Paige Marquez Yeowon Kim Shaokui Wei John R Su Mona Marin Source Type: research
Adult Vaccination
Am Fam Physician. 2022 Nov;106(5):534-542.ABSTRACTAdult vaccination rates are low in the United States, despite clear benefits for reducing morbidity and mortality. Vaccine science is evolving rapidly, and family physicians must maintain familiarity with the most recent guidelines. The recommended adult immunization schedule is updated annually by the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention. All eligible patients should receive SARS-CoV-2 vaccines according to the current guidelines. Adults without contraindications should also receive an annual influenza vaccine. Hepa...
Source: Herpes - November 15, 2022 Category: Infectious Diseases Authors: Grant M Greenberg Princy A Koshy Mary Jane S Hanson Source Type: research
Patterns of use of recombinant zoster vaccine among commercially-insured immunocompetent and immunocompromised adults 50-64 years old in the United States
CONCLUSIONS: RZV uptake was low in the two years since the CDC recommendation, and differed by demographic, healthcare access, and clinical characteristics. Initiation rates were higher among immunocompromised adults compared to immunocompetent adults, despite no CDC recommendation for vaccination in these groups during the study period. The CDC has since recommended RZV for immunocompromised individuals, and our findings may inform efforts to increase RZV uptake in individuals at higher risk of severe disease.PMID:36396511 | DOI:10.1016/j.vaccine.2022.10.076
Source: Vaccine - November 17, 2022 Category: Allergy & Immunology Authors: Jonathan Fix Nadja A Vielot Jennifer L Lund David J Weber Jennifer S Smith Michael G Hudgens Sylvia Becker-Dreps Source Type: research
Myoclonus status revealing COVID 19 infection
DISCUSSION: Our patient presented with acute isolated multifocal myoclonus status without cognitive impairment. These movements were prominent, spontaneous, worsened by action, and sensitive to touch and sound. The anatomical source of this myoclonus could be cortical or subcortical despite the absence of evident EEG discharges. Several diseases can cause acute myoclonus such as severe hypoxia, metabolic disturbances, and paraneoplastic syndromes. these diagnoses were ruled out in our patient. Post-vaccinal origin was also suggested, but its accountability was not proven. Thus, the two hypothetic etiologies raised were eit...
Source: Herpes - November 29, 2022 Category: Infectious Diseases Authors: Dina Ben Mohamed Rania Zouari Jihen Ketata Fatma Nabli Samir Blel Samia Ben Sassi Source Type: research
Lower dementia risk in patients vaccinated against herpes zoster
Conclusions: Among patients ≥65 years of age, HZ vaccination is associated with a 31-35% reduced risk of dementia. Confirmation in other study designs is warranted. Results may be explained by nonspecific neuroprotection and vaccination training the immune system to limit damaging inflammation. Results highlight the importance of HZ vaccination.PMID:36696249 | DOI:10.1370/afm.20.s1.2680
Source: Herpes - January 25, 2023 Category: Infectious Diseases Authors: Jeffrey Scherrer Joanne Salas Christine Jacobs Timothy Wiemken Source Type: research
